Q2 2026 revenues of $4.1 billion decreased by 1% in U.S. dollars year-over-year (YoY) and by 3% in local currency (LC) terms, ...
Kyverna Therapeutics stays a Strong Buy as miv-cel advances in SPS, gMG & refractory RA; BLA by Q4 2026 and key trial ...
An “unsophisticated” carpenter turned drug dealer from Melbourne’s northern outskirts who left a $430,000 drug money paper ...
The tiny aircraft buzz in big circles in a glimpse of agriculture’s new frontier — monitoring crops from the sky and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results